Studies have shown that carnitine deficiency is associated with a variety of metabolic diseases, including diabetes, obesity, cardiovascular disease, and chronic kidney disease
Its dual mechanism of action targets the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which are crucial for regulating insulin secretion, improving insulin sensitivity, and reducing glucagon levels
This has commercial implications as semaglutides classification affects its development cost, time-to-market and pricing expectations
Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells
Improved Overall Well-being: Weight loss with GLP-1 is often accompanied by increased energy levels, improved mood, and a better quality of life